Pfizer unveils new consumer Web site

Share this article:
Pfizer unveils new consumer Web site
Pfizer unveils new consumer Web site

Pfizer has launched a refreshed consumer Web site at www.pfizer.com featuring a cleaner design and

new features.

“I think the site is warmer and more emotional in tone than the previous one, and it's reflective of what we've heard from our survey (of users),” Pfizer spokesman Andy McCormack told MM&M.

For Pfizer.com's first Web site makeover in nearly three years, the company worked with Grey unit G2 Direct and Digital to incorporate a product search on every single page.

“We've made it easier for our users to access our updated product information,” Pfizer spokeswoman Kate Bird added. “We've also incorporated a technology called Ajax, which is a combination of JavaScript and XML. That gives us the opportunity to highlight and promote certain events and programs without taking the user several clicks into the site.”

Other new Pfizer.com features include automated Securities and Exchange Commission filings and a more robust investor dashboard for Pfizer's investor population.

Also, a new R&D section features information of Pfizer's product pipeline as well as post-marketing commitments that are updated on a weekly basis.

Pfizer.com averages about 4 million visitors per year. That audience is comprised of both consumers and health care professionals, according to Bird.

Share this article:

Email Newsletters

More in News

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...

Pfizer Q2 sales slip, but still beat expectations

Pfizer Q2 sales slip, but still beat expectations

Patent losses and lost co-promotion agreements put a dent in sales.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?